Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer

Por Androulakis, N, Agelaki, S, Perraki, M, Apostolaki, S, Bozionelou, V, Pallis, A, Kalbakis, K, Xyrafas, A, Mavroudis, D, Georgoulias, V
Publicado em 2012

Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib

Por Koutsoukos K, Bamias A, Tzannis K, Espinosa Montaño M, Bozionelou V, Christodoulou C, Stefanou D, Kalofonos H, Duran I, Papazisis K
Publicado em 2017-10-01

A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours

Por Bozionelou, V, Vamvakas, L, Pappas, P, Agelaki, S, Androulakis, N, Kalykaki, A, Nikolaidou, M, Kentepozidis, N, Giassas, S, Marselos, M, Georgoulias, V, Mavroudis, D
Publicado em 2007